Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Revenues climbed 47 times or 4757%
revenues climbed from $1,755 to $83,500 for the 3 months ended September 30. up 47 times more or 4757%
VDRM
Viaderma Inc is a pharmaceutical company focused on bringing new products to the pharmaceutical industry through research and development. With that, it licenses and sells products in fields of medicine ranging from infectious diseases to stem-cell therapy. The company’s products are distributed over-the-counter and are applied topically using a delivery system technology.
Aside from developing and selling new products to the market, Viaderma Inc is exploring the possibility of licensing the technology to other pharmaceutical companies. It has products in development in various fields, including topical antibiotics (TetraStem), topical anti-viral product (Viralcur) for genital herpes, anti-fungal products for onychomycocis (OnyPro), hair loss prevention product (HairGain), skin cancer therapies (Cantrile), and a topical stem cell therapy product (TetraStem Plus).
VDRM
The company is also seeking to venture in the cannabis industry, which is set to reach $20 billion by 2020 thanks to the outcome of the November 8 vote to legalize the use of medical or recreational marijuana in several states. The company announced the Patent Pending use of its innovative transdermal system for the delivery of Calanoids and Tetrahydrocannabinol for the treatment of several diseases.
With that, the company has several potential revenue streams lined up and the commercialization of its products could lend tremendous upside to share prices. CBD is often used for the reduction of inflammation and for the treatment of several diseases, such as, nicotine addiction, fibromyalgia, Cohn’s disease, schizophrenia, migraine headaches, pain management for cancer and Multiple Sclerosis and the addition of transdermal delivery can spur immediate absorption into the bloodstream.
VDRM
“We are also in the clinical testing stages of an anti-aging topical solution, topical pain medication, a topical for male-pattern baldness, and a topical designed to boost male libido,” said Viaderma Inc CEO Dr. Christopher Otiko. “We are enthusiastic about the results we have achieved to date in terms of the anecdotal feedback we have received from the medical community. We are also in early-stage discussion with two companies to private label Viabecline for distribution in the Middle East, Asia and North Africa, and Europe.”
VDRM
In a press release this week, Viaderma Inc shared that several patients have had significant treatment success with the use of its innovative transdermal system for the delivery of its FDA registered drug, Viabecline. This is a topical liquid tetracycline-based antibiotic that uses a patent-pending innovative transdermal delivery system that can convert oral medication active ingredients into topical drugs and is registered as a first aid antibiotic to help prevent skin infection in minor cuts, scrapes, and burns.
The results were achieved in just 10 days of treatment using the company’s proprietary patent-pending transdermal delivery system, which can deliver medications and nutrients into the body through the skin and increase the absorption as much as 100 times directly to the localized treatment areas.
VDRM
"As of September 30, 2016, the Company had accounts receivable of $169,980, all of which was from related party, and the allowance for uncollectible accounts was $0."
VDRM
"We are attempting to negotiate payoffs on most of our promissory notes which, if successful, would remove most of our future interest charges."
VDRM
The Company had revenues of $83,500 and $209,573 for the three and nine months ended September 30, 2016, respectively, compared to revenues of $1,755 and $20,212 for the three and nine months ended September 30, 2015, respectively.
revenues climbed from $1,755 to $83,500 for the 3 months ended September 30. up 47 times more or 4757%
revenues climbed from $20,212 to $209,573 for the 9 months ended September 30. up 10 times more or 1036%
VDRM
Beneficial owners.
Provide a list of the name, address and shareholdings of all persons beneficially owning more than five percent (5%)
of any class of the issuer's equity securities as of September 30, 2016.
Dr. Chris Ayo Otiko................ 44,000,000 21.96% (CEO)
Greentree Financial Group Inc.......12,000,000 5.99%
Maurice Katz 295.................... 8,507,017 4.25%
VDRM
bid 2M 0005
They stayed in good hands
let's go !
GMNI
Bullish Prospects Lining Up for Viaderma Inc (OTCMKTS:VDRM)
http://www.forexminute.com/bullish-prospects-lining-up-for-viaderma-inc-otcmktsvdrm/
The sale of the 7M of only one person caused this fall.
bid 10.7M let's go
7M were dumped.
They stayed in good hands :)
agree. let's go
0009 up +12%
GMNI
look WCIG similar stock and up, High 52 weeks..
GMNI will start at any time.
Now, to make it explode:
1) CEO should remove the restrictive 300M he owns.
2) and give news.
0.02-0.03 52 weeks
Ask 710K 11 ; 500K 15
BOOOM 11 12 15 1.2M shares only
GMNI - good potential
MACD & RSI Ready to explode
Potencial Merger / acquisition MJ
In addition to the progress made with Bootleg Elixir Premium E-Liquids, Gemini has also been very active in seeking out established vaping retail shops in several states for potential acquisition. If successful, this growth by acquisition strategy should allow Gemini to rapidly ramp up revenues, buildout its retail brand in new states, and also expand the Company's ability to market and distribute its own growing line of Gemini vaping products like Bootleg Elixir, vaporizers, mods, and other vaping accessories.
GMNI - Marijuana Stock in the Making?
http://newsletters.getresponse.com/archive/jetlife/Marijuana-Stock-In-The-Making-Stealth-Bull-Breakout-Trade-Details-134439001.html
Gemini Vapour Interview on New to the Street
http://newtothestreet.tv/video/interview-christopher-cox-ceo-gemini-vapour
share structure Float unchanged
Confirmed November 16, 2016.
Float 374M
CEO 300M
$GMNI
<<<< GMNI DD >>>>>
MACD & RSI Ready to explode
Potencial Merger / acquisition MJ
In addition to the progress made with Bootleg Elixir Premium E-Liquids, Gemini has also been very active in seeking out established vaping retail shops in several states for potential acquisition. If successful, this growth by acquisition strategy should allow Gemini to rapidly ramp up revenues, buildout its retail brand in new states, and also expand the Company's ability to market and distribute its own growing line of Gemini vaping products like Bootleg Elixir, vaporizers, mods, and other vaping accessories.
GMNI - Marijuana Stock in the Making?
http://newsletters.getresponse.com/archive/jetlife/Marijuana-Stock-In-The-Making-Stealth-Bull-Breakout-Trade-Details-134439001.html
Gemini Vapour Interview on New to the Street
http://newtothestreet.tv/video/interview-christopher-cox-ceo-gemini-vapour
share structure Float unchanged
Confirmed November 16, 2016.
Float 374M
CEO 300M
$GMNI
GMNI - Ready to explode
MACD & RSI Ready to explode
Potencial Merger / acquisition MJ
In addition to the progress made with Bootleg Elixir Premium E-Liquids, Gemini has also been very active in seeking out established vaping retail shops in several states for potential acquisition. If successful, this growth by acquisition strategy should allow Gemini to rapidly ramp up revenues, buildout its retail brand in new states, and also expand the Company's ability to market and distribute its own growing line of Gemini vaping products like Bootleg Elixir, vaporizers, mods, and other vaping accessories.
GMNI - Marijuana Stock in the Making?
http://newsletters.getresponse.com/archive/jetlife/Marijuana-Stock-In-The-Making-Stealth-Bull-Breakout-Trade-Details-134439001.html
Gemini Vapour Interview on New to the Street
http://newtothestreet.tv/video/interview-christopher-cox-ceo-gemini-vapour
share structure Float unchanged
Confirmed November 16, 2016.
Float 374M
CEO 300M
$GMNI
up +100% this week
$GMNI
100% buys
charts
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=126742142
$GMNI
GMNI 0.001 up +42%
Potencial Merger / acquisition MMJ - GMNI
In addition to the progress made with Bootleg Elixir Premium E-Liquids, Gemini has also been very active in seeking out established vaping retail shops in several states for potential acquisition. If successful, this growth by acquisition strategy should allow Gemini to rapidly ramp up revenues, buildout its retail brand in new states, and also expand the Company's ability to market and distribute its own growing line of Gemini vaping products like Bootleg Elixir, vaporizers, mods, and other vaping accessories.
GMNI - Marijuana Stock in the Making?
http://newsletters.getresponse.com/archive/jetlife/Marijuana-Stock-In-The-Making-Stealth-Bull-Breakout-Trade-Details-134439001.html
$GMNI
Gemini Group Global Corp. and Royal Vapour are also partners in creating a new Bootleg elixir line of e-liquid as well as the production and distribution of Mods.
Gemini Group Global Corp. has issued a sizable amount of shares of the company to Royal Vapour (past) along with a commitment of raising up a sizable investment into the new company line. (Present / future) (creating a new Bootleg elixir line of e-liquid) = MMJ ?! The funds would be for growing the business in the categories above.
share structure Float unchanged
Confirmed November 16, 2016.
Float 374M
CEO 300M
up +42%
Potencial Merger / acquisition MMJ - GMNI
In addition to the progress made with Bootleg Elixir Premium E-Liquids, Gemini has also been very active in seeking out established vaping retail shops in several states for potential acquisition. If successful, this growth by acquisition strategy should allow Gemini to rapidly ramp up revenues, buildout its retail brand in new states, and also expand the Company's ability to market and distribute its own growing line of Gemini vaping products like Bootleg Elixir, vaporizers, mods, and other vaping accessories.
GMNI - Marijuana Stock in the Making?
http://newsletters.getresponse.com/archive/jetlife/Marijuana-Stock-In-The-Making-Stealth-Bull-Breakout-Trade-Details-134439001.html
$GMNI
Gemini Group Global Corp. and Royal Vapour are also partners in creating a new Bootleg elixir line of e-liquid as well as the production and distribution of Mods.
Gemini Group Global Corp. has issued a sizable amount of shares of the company to Royal Vapour (past) along with a commitment of raising up a sizable investment into the new company line. (Present / future) (creating a new Bootleg elixir line of e-liquid) = MMJ ?! The funds would be for growing the business in the categories above.
share structure Float unchanged
Confirmed November 16, 2016.
Float 374M
CEO 300M
Potencial Merger / acquisition MMJ - GMNI - up +42%
In addition to the progress made with Bootleg Elixir Premium E-Liquids, Gemini has also been very active in seeking out established vaping retail shops in several states for potential acquisition. If successful, this growth by acquisition strategy should allow Gemini to rapidly ramp up revenues, buildout its retail brand in new states, and also expand the Company's ability to market and distribute its own growing line of Gemini vaping products like Bootleg Elixir, vaporizers, mods, and other vaping accessories.
GMNI - Marijuana Stock in the Making?
http://newsletters.getresponse.com/archive/jetlife/Marijuana-Stock-In-The-Making-Stealth-Bull-Breakout-Trade-Details-134439001.html
$GMNI
Gemini Group Global Corp. and Royal Vapour are also partners in creating a new Bootleg elixir line of e-liquid as well as the production and distribution of Mods.
Gemini Group Global Corp. has issued a sizable amount of shares of the company to Royal Vapour (past) along with a commitment of raising up a sizable investment into the new company line. (Present / future) (creating a new Bootleg elixir line of e-liquid) = MMJ ?! The funds would be for growing the business in the categories above.
share structure Float unchanged
Confirmed November 16, 2016.
Float 374M
CEO 300M
GMNI up +42% 0.001
Potencial Merger / acquisition MMJ - GMNI
In addition to the progress made with Bootleg Elixir Premium E-Liquids, Gemini has also been very active in seeking out established vaping retail shops in several states for potential acquisition. If successful, this growth by acquisition strategy should allow Gemini to rapidly ramp up revenues, buildout its retail brand in new states, and also expand the Company's ability to market and distribute its own growing line of Gemini vaping products like Bootleg Elixir, vaporizers, mods, and other vaping accessories.
GMNI - Marijuana Stock in the Making?
http://newsletters.getresponse.com/archive/jetlife/Marijuana-Stock-In-The-Making-Stealth-Bull-Breakout-Trade-Details-134439001.html
$GMNI
Gemini Group Global Corp. and Royal Vapour are also partners in creating a new Bootleg elixir line of e-liquid as well as the production and distribution of Mods.
Gemini Group Global Corp. has issued a sizable amount of shares of the company to Royal Vapour (past) along with a commitment of raising up a sizable investment into the new company line. (Present / future) (creating a new Bootleg elixir line of e-liquid) = MMJ ?! The funds would be for growing the business in the categories above.
share structure Float unchanged
Confirmed November 16, 2016.
Float 374M
CEO 300M